Direxion Daily S&P Biotech Bull 3X Shares (BMV:LABU)
990.00
-5.94 (-0.60%)
Last updated: May 22, 2025
BMV:LABU Holdings List
As of May 22, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | n/a | Goldman Sachs Sterling FixInc Port Inc | 19.56% |
2 | n/a | Dreyfus Govt Cash Man Ins | 19.28% |
3 | n/a | Goldman Sachs Fin Gov 465 Institut | 6.95% |
4 | n/a | Dreyfus Trsry Securities Cash Mgmt | 6.48% |
5 | n/a | S&P Biotechnology Select Industry Index Swap | 3.87% |
6 | n/a | Cash | 2.87% |
7 | EXAS | Exact Sciences Corporation | 2.15% |
8 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.11% |
9 | NBIX | Neurocrine Biosciences, Inc. | 1.93% |
10 | NTRA | Natera, Inc. | 1.87% |
11 | UTHR | United Therapeutics Corporation | 1.78% |
12 | INCY | Incyte Corporation | 1.68% |
13 | GILD | Gilead Sciences, Inc. | 1.65% |
14 | BPMC | Blueprint Medicines Corporation | 1.63% |
15 | EXEL | Exelixis, Inc. | 1.61% |
16 | BIIB | Biogen Inc. | 1.59% |
17 | INSM | Insmed Incorporated | 1.58% |
18 | VRTX | Vertex Pharmaceuticals Incorporated | 1.55% |
19 | AMGN | Amgen Inc. | 1.54% |
20 | REGN | Regeneron Pharmaceuticals, Inc. | 1.53% |
21 | ABBV | AbbVie Inc. | 1.52% |
22 | MRNA | Moderna, Inc. | 1.35% |
23 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.34% |
24 | BMRN | BioMarin Pharmaceutical Inc. | 1.24% |
25 | BBIO | BridgeBio Pharma, Inc. | 1.09% |
26 | RVMD | Revolution Medicines, Inc. | 1.04% |
27 | TGTX | TG Therapeutics, Inc. | 1.02% |
28 | HALO | Halozyme Therapeutics, Inc. | 0.98% |
29 | SMMT | Summit Therapeutics Inc. | 0.97% |
30 | IONS | Ionis Pharmaceuticals, Inc. | 0.96% |
31 | CRSP | CRISPR Therapeutics AG | 0.90% |
32 | ROIV | Roivant Sciences Ltd. | 0.89% |
33 | SWTX | SpringWorks Therapeutics, Inc. | 0.84% |
34 | VKTX | Viking Therapeutics, Inc. | 0.83% |
35 | ALKS | Alkermes plc | 0.74% |
36 | ADMA | ADMA Biologics, Inc. | 0.74% |
37 | CYTK | Cytokinetics, Incorporated | 0.74% |
38 | PCVX | Vaxcyte, Inc. | 0.73% |
39 | RNA | Avidity Biosciences, Inc. | 0.73% |
40 | ACAD | ACADIA Pharmaceuticals Inc. | 0.71% |
41 | ACLX | Arcellx, Inc. | 0.62% |
42 | SRPT | Sarepta Therapeutics, Inc. | 0.62% |
43 | NUVL | Nuvalent, Inc. | 0.61% |
44 | AKRO | Akero Therapeutics, Inc. | 0.59% |
45 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.59% |
46 | SLNO | Soleno Therapeutics, Inc. | 0.56% |
47 | SRRK | Scholar Rock Holding Corporation | 0.56% |
48 | APLS | Apellis Pharmaceuticals, Inc. | 0.52% |
49 | RARE | Ultragenyx Pharmaceutical Inc. | 0.52% |
50 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.50% |
51 | VCYT | Veracyte, Inc. | 0.50% |
52 | KRYS | Krystal Biotech, Inc. | 0.50% |
53 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.49% |
54 | TWST | Twist Bioscience Corporation | 0.46% |
55 | AGIO | Agios Pharmaceuticals, Inc. | 0.45% |
56 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.43% |
57 | PTCT | PTC Therapeutics, Inc. | 0.42% |
58 | CPRX | Catalyst Pharmaceuticals, Inc. | 0.41% |
59 | RXRX | Recursion Pharmaceuticals, Inc. | 0.41% |
60 | GRAL | GRAIL, Inc. | 0.39% |
61 | MIRM | Mirum Pharmaceuticals, Inc. | 0.37% |
62 | TVTX | Travere Therapeutics, Inc. | 0.37% |
63 | IDYA | IDEAYA Biosciences, Inc. | 0.37% |
64 | CLDX | Celldex Therapeutics, Inc. | 0.36% |
65 | ARQT | Arcutis Biotherapeutics, Inc. | 0.36% |
66 | BEAM | Beam Therapeutics Inc. | 0.34% |
67 | PTGX | Protagonist Therapeutics, Inc. | 0.33% |
68 | NVAX | Novavax, Inc. | 0.33% |
69 | IMVT | Immunovant, Inc. | 0.33% |
70 | VCEL | Vericel Corporation | 0.32% |
71 | SNDX | Syndax Pharmaceuticals, Inc. | 0.30% |
72 | BHVN | Biohaven Ltd. | 0.30% |
73 | CGON | CG Oncology, Inc. | 0.30% |
74 | KYMR | Kymera Therapeutics, Inc. | 0.29% |
75 | DNLI | Denali Therapeutics Inc. | 0.29% |
76 | DYN | Dyne Therapeutics, Inc. | 0.29% |
77 | APGE | Apogee Therapeutics, Inc. | 0.28% |
78 | NTLA | Intellia Therapeutics, Inc. | 0.28% |
79 | CDNA | CareDx, Inc | 0.28% |
80 | VERA | Vera Therapeutics, Inc. | 0.27% |
81 | IRON | Disc Medicine, Inc. | 0.27% |
82 | DVAX | Dynavax Technologies Corporation | 0.26% |
83 | FOLD | Amicus Therapeutics, Inc. | 0.26% |
84 | ARDX | Ardelyx, Inc. | 0.25% |
85 | VRDN | Viridian Therapeutics, Inc. | 0.24% |
86 | JANX | Janux Therapeutics, Inc. | 0.23% |
87 | ETNB | 89bio, Inc. | 0.22% |
88 | GERN | Geron Corporation | 0.21% |
89 | QURE | uniQure N.V. | 0.21% |
90 | PRAX | Praxis Precision Medicines, Inc. | 0.18% |
91 | MNKD | MannKind Corporation | 0.18% |
92 | NRIX | Nurix Therapeutics, Inc. | 0.18% |
93 | SPRY | ARS Pharmaceuticals, Inc. | 0.18% |
94 | SYRE | Spyre Therapeutics, Inc. | 0.17% |
95 | RCKT | Rocket Pharmaceuticals, Inc. | 0.17% |
96 | RCUS | Arcus Biosciences, Inc. | 0.16% |
97 | AVXL | Anavex Life Sciences Corp. | 0.16% |
98 | CAPR | Capricor Therapeutics, Inc. | 0.15% |
99 | IBRX | ImmunityBio, Inc. | 0.14% |
100 | IMNM | Immunome, Inc. | 0.14% |
101 | COGT | Cogent Biosciences, Inc. | 0.14% |
102 | ALT | Altimmune, Inc. | 0.14% |
103 | KURA | Kura Oncology, Inc. | 0.13% |
104 | VIR | Vir Biotechnology, Inc. | 0.13% |
105 | KROS | Keros Therapeutics, Inc. | 0.13% |
106 | DAWN | Day One Biopharmaceuticals, Inc. | 0.12% |
107 | IOVA | Iovance Biotherapeutics, Inc. | 0.12% |
108 | EBS | Emergent BioSolutions Inc. | 0.12% |
109 | REPL | Replimune Group, Inc. | 0.11% |
110 | XNCR | Xencor, Inc. | 0.11% |
111 | ANAB | AnaptysBio, Inc. | 0.11% |
112 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.10% |
113 | STOK | Stoke Therapeutics, Inc. | 0.10% |
114 | AKBA | Akebia Therapeutics, Inc. | 0.10% |
115 | RLAY | Relay Therapeutics, Inc. | 0.10% |
116 | MYGN | Myriad Genetics, Inc. | 0.09% |
117 | VERV | Verve Therapeutics, Inc. | 0.08% |
118 | ORIC | ORIC Pharmaceuticals, Inc. | 0.08% |
119 | HUMA | Humacyte, Inc. | 0.07% |
120 | MDXG | MiMedx Group, Inc. | 0.07% |
121 | DNTH | Dianthus Therapeutics, Inc. | 0.07% |
122 | CGEM | Cullinan Therapeutics, Inc. | 0.07% |
123 | RIGL | Rigel Pharmaceuticals, Inc. | 0.07% |
124 | SANA | Sana Biotechnology, Inc. | 0.06% |
125 | AVBP | ArriVent BioPharma, Inc. | 0.06% |
126 | KALV | KalVista Pharmaceuticals, Inc. | 0.05% |
127 | PRTA | Prothena Corporation plc | 0.05% |
128 | ABUS | Arbutus Biopharma Corporation | 0.04% |
129 | ORGO | Organogenesis Holdings Inc. | 0.02% |
130 | SCLX | Scilex Holding Company | 0.01% |
131 | n/a | Inhibrx Inc Cvr | 0.00% |
132 | n/a | Omniab Inc - 12.5 Earnout | 0.00% |
133 | n/a | Omniab Inc - 15.00 Earnout | 0.00% |
134 | n/a | Ubs Collateral | -1.86% |
135 | n/a | Barclays Collateral | -4.40% |
136 | n/a | S&P Biotechnology Select Industry Index Swap | -19.41% |
As of May 22, 2025